Search

Your search keyword '"Neuhausen S"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Neuhausen S" Remove constraint Author: "Neuhausen S" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
57 results on '"Neuhausen S"'

Search Results

1. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis

2. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations

3. MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations

4. The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

5. Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation

6. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

7. Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers

8. The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT

9. Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal

10. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

11. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

12. Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers

13. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

14. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

15. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

16. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

17. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

18. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation

19. Shared heritability and functional enrichment across six solid cancers

20. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

21. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

22. Genome-wide association study of germline variants and breast cancer-specific mortality

23. Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers

24. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

25. Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2

26. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

27. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

28. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

29. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

30. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

31. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

32. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

33. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

34. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

35. Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

36. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

37. COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration

38. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

39. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

40. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

41. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

42. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

43. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

44. Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort

45. Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort

46. Multiple common variants for celiac disease influencing immune gene expression

47. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers : Implications for risk prediction

48. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers : Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

49. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

50. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

Catalog

Books, media, physical & digital resources